Cytomegalovirus-Specific T-Cell Transfer for Refractory Cytomegalovirus Infection After Haploidentical Stem Cell Transplantation: The Quantitative and Qualitative Immune Recovery for Cytomegalovirus

How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients

(2016) F. El Chaer et al.   BLOOD

Poor CMV-specific CD8+ T central memory subset recovery at early stage post-HSCT associates with refractory and recurrent CMV reactivation

(2016) Jing Liu et al.   JOURNAL OF INFECTION

CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire

(2015) Yvonne Suessmuth et al.   BLOOD

Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality

(2015) J. Liu et al.   CLINICAL MICROBIOLOGY AND INFECTION

Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirus

(2015) Verena Pfirrmann et al.   CYTOTHERAPY

IL-12–Dependent Cytomegalovirus-Specific CD4+T Cell Proliferation, T-bet Induction, and Effector Multifunction during Primary Infection Are Key Determinants for Early Immune Control

(2015) Iulia Popescu et al.   JOURNAL OF IMMUNOLOGY

Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8+T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation

(2015) E. Giménez et al.   Transplant Infectious Disease

T cell exhaustion during persistent viral infections

(2015) Shannon M. Kahan et al.   VIROLOGY

CMV promotes recipient T-cell immunity following reduced-intensity T-cell-depleted HSCT, significantly modulating chimerism status

(2014) R. S. Sellar et al.   BLOOD

Correlations of programmed death 1 expression and serum IL-6 level with exhaustion of cytomegalovirus-specific T cells after allogeneic hematopoietic stem cell transplantation

(2014) Tomonori Kato et al.   CELLULAR IMMUNOLOGY

T-bet:Eomes Balance, Effector Function, and Proliferation of Cytomegalovirus-Specific CD8+T Cells during Primary Infection Differentiates the Capacity for Durable Immune Control

(2014) Iulia Popescu et al.   JOURNAL OF IMMUNOLOGY

Improving Cytomegalovirus-Specific T Cell Reconstitution after Haploidentical Stem Cell Transplantation

(2014) Xiao-Hua Luo et al.   Journal of Immunology Research

PD-1 Analysis on CD28−CD27−CD4 T Cells Allows Stimulation-Independent Assessment of CMV Viremic Episodes in Transplant Recipients

(2013) J. Dirks et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation

(2013) E. Blyth et al.   BLOOD

High Rate of Cytomegalovirus Drug Resistance Among Patients Receiving Preemptive Antiviral Treatment After Haploidentical Stem Cell Transplantation

(2013) Einat Shmueli et al.   JOURNAL OF INFECTIOUS DISEASES

Functional Exhaustion of CD4+ T Lymphocytes during Primary Cytomegalovirus Infection

(2012) P. Antoine et al.   JOURNAL OF IMMUNOLOGY

Protective Immunity Transferred by Infusion of Cytomegalovirus-Specific CD8+ T Cells within Donor Grafts: Its Associations with Cytomegalovirus Reactivation Following Unmanipulated Allogeneic Hematopoietic Stem Cell Transplantation

(2010) Xiao-Hua Luo et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation

(2010) T. Feuchtinger et al.   BLOOD

Increased Programmed Death-1 Molecule Expression in Cytomegalovirus Disease and Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation

(2009) Ghislaine M. Gallez-Hawkins et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Cytomegalovirus‐Specific T Cell Immunotherapy Promotes Restoration of Durable Functional Antiviral Immunity following Allogeneic Stem Cell Transplantation

(2009) Karl S. Peggs et al.   CLINICAL INFECTIOUS DISEASES

Adoptive T cell immunotherapy for cytomegalovirus

(2009) Karl S Peggs   EXPERT OPINION ON BIOLOGICAL THERAPY

PD-1 Expression and IL-2 Loss of Cytomegalovirus- Specific T Cells Correlates with Viremia and Reversible Functional Anergy

(2008) U. Sester et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Programmed Death–1 Expression in Liver Transplant Recipients as a Prognostic Indicator of Cytomegalovirus Disease

(2007) Corinna La Rosa et al.   JOURNAL OF INFECTIOUS DISEASES